NCT00307021View on ClinicalTrials.gov

Double-blind Study of Safety and Immunogenicity of Two Candidate Malaria Vaccines in Gabonese Children

PHASE2CompletedINTERVENTIONAL

Enrollment

180

Participants

Timeline

Start Date

April 7, 2006

Primary Completion Date

September 15, 2006

Study Completion Date

August 22, 2007

Conditions

Malaria

Interventions

BIOLOGICAL

GSK Biologicals' candidate Plasmodium falciparum malaria vaccine 257049

3-dose intramuscular injection, 2 different formulations

Trial Locations (1)

Unknown

GSK Investigational Site, Lambaréné

Sponsors

Lead Sponsor

GlaxoSmithKline

All Listed Sponsors

lead

GlaxoSmithKline

INDUSTRY